Post Thyroidectomy Echographic Method for Study of Vocal Fold Motion (VOCALE)
Recurrent Laryngeal Nerve Palsy, Postoperative Dysphonia
About this trial
This is an interventional diagnostic trial for Recurrent Laryngeal Nerve Palsy focused on measuring Postoperative dysphonia, Thyroidectomy, Parathyroidectomy, Inferior laryngeal nerve palsy, Trans laryngeal ultrasonography, Quantitative vocal fold motion evaluation, Postoperative recurrent Laryngeal Nerve Palsy
Eligibility Criteria
Inclusion Criteria:
- 18 years old patient and older
- Free informed consent of the patient obtained during the preoperative consultation or, failing this, the day before the intervention during the preoperative hospitalization
- Thyroid / parathyroid surgery scheduled within 3 months, regardless of the indication or extension
- Affiliation to a social security system (recipient or assign) excluding AME.
Exclusion criteria
- Known preoperative history of recurrent nerve palsy
- History of thyroid or parathyroid surgery or cervicotomy for another pathology
- History of laryngeal tumor or vocal folds
- Patient under guardianship or curatorship or deprived of liberty or under judicial protection
- Pregnant, breastfeeding and parturient women
Sites / Locations
- CHU Nantes - Clinique de chirurgie Digestive et EndocrinienneRecruiting
- Hopital Pitié-Salpêtrière
- Hopital AvicenneRecruiting
- Hopital Cochin
- Institut Gustave Roussy (IGR)Recruiting
Arms of the Study
Arm 1
Experimental
Transcutaneous Laryngeal Ultrasonography
All patients operated on endocrine surgery in the three referral centers and responding to the inclusion criteria will be included after obtaining their writing consent. The gold standard NF will be performed between D1 and D15, as usually performed after these surgeries. TLU will be performed during the same time period by an investigator blind to the NF results. The subject will be his own control, NF and TLU being compared. When facing VF immobility, the subject will benefit from the usual clinical follow up: consultation with NF at 6 weeks and 6 months. TLU will be added to these appointments.